A comparison of the binding sites of antibodies and single-domain antibodies [PDF]
Frontiers in Immunology, 2023 Antibodies are the largest class of biotherapeutics. However, in recent years, single-domain antibodies have gained traction due to their smaller size and comparable binding affinity.
Gemma L. Gordon +5 more
doaj +7 more sources
Species-Dependent Structural Variations in Single-Domain Antibodies [PDF]
AntibodiesBackground/Objectives: Single-domain antibodies (sdAbs) are derived from camelid heavy-chain antibodies (HCAb). Their small size, high stability, and ease of production, among other properties, makes them highly valuable in biomedical research and ...
Marta Baselga +3 more
doaj +2 more sources
Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses [PDF]
Nature CommunicationsInfluenza B viruses are antigenically diverse and contribute significantly to the annual influenza burden. Here we report influenza B virus neutralizing single-domain antibodies that target highly conserved regions of the hemagglutinin and neuraminidase.
Arne Matthys +9 more
doaj +2 more sources
Transportation of Single-Domain Antibodies through the Blood–Brain Barrier
Biomolecules, 2021 Single-domain antibodies derive from the heavy-chain-only antibodies of Camelidae (camel, dromedary, llama, alpaca, vicuñas, and guananos; i.e., nanobodies) and cartilaginous fishes (i.e., VNARs).
Eduardo Ruiz-López +1 more
doaj +3 more sources
Inhibition of tau neuronal internalization using anti-tau single domain antibodies [PDF]
Nature CommunicationsIn Alzheimer’s disease, tau pathology spreads across brain regions as the disease progresses. Intracellular tau can be released and taken up by nearby neurons.
Clément Danis +12 more
doaj +2 more sources
Single-domain antibodies as therapeutics for solid tumor treatment [PDF]
Acta Pharmaceutica Sinica BSingle-domain antibodies (sdAbs), initially identified in camelids or sharks and commonly referred to as nanobodies or VNARs, have emerged as a promising alternative to conventional therapeutic antibodies.
Mingkai Wang, Tianlei Ying, Yanling Wu
doaj +2 more sources
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer [PDF]
EJNMMI Radiopharmacy and ChemistryBackground Radiofluorination of single domain antibodies (sdAbs) via N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) has shown to be a promising strategy in the development of sdAb-based PET tracers. While automation of the prosthetic group (PG) [18F]SFB
Herlinde Dierick +11 more
doaj +2 more sources
Single domain antibodies from camelids in the treatment of microbial infections [PDF]
Frontiers in ImmunologyInfectious diseases continue to pose significant global health challenges. In addition to the enduring burdens of ailments like malaria and HIV, the emergence of nosocomial outbreaks driven by antibiotic-resistant pathogens underscores the ongoing ...
Henri De Greve +3 more
doaj +2 more sources
Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies) [PDF]
Cancers, 2023 Haiming Huang +2 more
exaly +2 more sources
Immunogenicity and humanization of single‐domain antibodies [PDF]
The FEBS Journal, 2021 Single‐domain antibodies (sdAbs), the autonomous variable domains of camelid and shark heavy‐chain antibodies, have many desirable properties as components of biologic drugs. However, their sequences may increase the risk of immunogenicity and antidrug antibody (ADA) development in humans, and thus, sdAbs are routinely humanized during development ...
Rossotti, Martin A. +3 more
openaire +2 more sources